http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112180013-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b22efb90b858e712e08ce5e9e5395040 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a7c7edd3db2e9cd449ed73c2c34717c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-324 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56916 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate | 2020-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3fa551d94786f38c41a490a15ccaf62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b27f6e93afebe84a8ffb9b81ba41957 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_612707ad283bf04d4c3aeb9ae2a80c74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_976c6ea6897af57e9e3e2d41cf16fa37 |
| publicationDate | 2021-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112180013-A |
| titleOfInvention | Intestinal microbial metabolic marker composition for the diagnosis of myocardial infarction and its detection method and application |
| abstract | The invention provides an intestinal microbial metabolism marker composition for the diagnosis of myocardial infarction, comprising one or more of acetyl-L-carnitine, γ-butyl betaine and choline chloride. Preferably, the intestinal microbial metabolic marker composition for the diagnosis of myocardial infarction includes choline chloride and acetyl-L-carnitine. Compositions of gut microbial metabolic markers for myocardial infarction diagnosis include choline chloride and γ-butyl betaine. Compositions of gut microbial metabolic markers for myocardial infarction diagnosis include choline chloride, acetyl-L-carnitine, and γ-butyl betaine. Related detection methods and applications are also provided. The intestinal microbial metabolic marker composition for the diagnosis of myocardial infarction of the present invention can be used for the diagnosis of myocardial infarction, can diagnose myocardial infarction accurately, rapidly, with high specificity and high sensitivity, provides guarantee for the early treatment as soon as possible, and is suitable for the diagnosis of myocardial infarction. Large-scale promotion of applications. |
| priorityDate | 2020-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 227.